hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06327126, orgStudyIdInfo id: BFHHZS20240001, briefTitle: Efficacy and Safety of Single-session Endoscopic Stone Extraction, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2024-05-01, completionDateStruct date: 2024-05-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-18, sponsorCollaboratorsModule leadSponsor name: Beijing Friendship Hospital, class: OTHER, descriptionModule briefSummary: This is a retrospective study, including approximately 600 patients with acute cholangitis accompanied with choledocholithiasis, who treated with single-session or two-session endoscopic stone extraction at Beijing friendship hospital. The investigators assessed the outcomes of single-stage and two-stage endoscopic stone extraction., conditionsModule conditions: Choledocholithiasis With Acute Cholangitis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 600, type: ESTIMATED, armsInterventionsModule interventions name: two-session ERCP, interventions name: single-session ERCP, outcomesModule primaryOutcomes measure: Success rate of complete stone removal, primaryOutcomes measure: ERCP-related complication rate, secondaryOutcomes measure: Length of stay, secondaryOutcomes measure: Hospital expenses, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Beijing Friendship Hospital, status: RECRUITING, city: Beijing, state: Beijing, zip: 100050, country: China, contacts name: Wei Jiang, role: CONTACT, phone: 18663186116, email: jfw899w@outlook.com, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06327113, orgStudyIdInfo id: IRB#23-001248, briefTitle: Antibiotic Tumescent For Chronic Wounds, acronym: TAI, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-25, primaryCompletionDateStruct date: 2027-03-25, completionDateStruct date: 2028-03-25, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: University of California, Los Angeles, class: OTHER, descriptionModule briefSummary: Chronic non-healing wounds are becoming an increasingly more common problem. Eligible, consenting patients with chronic leg wounds will either continue to the standard of care or will be randomized to the treatment cohort where antibiotic solution will be injected in the area around the wound. All patients will continue standard wound care as dictated by the wound care clinic. Subjects of both the control and treatment will have approximately 6 study specific visits that may or may not coincide with previously schedule wound care clinic visits. As these specified visits wound size and healing will be documented and patients will complete surveys. The study will conclude for the subject after approximately 6 months. Again, these patients may continue standard wound care but will no longer have study obligations., conditionsModule conditions: Non-healing Wound, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: This is a single center, prospective, comparative interventional, two-arm parallel group, randomized, clinical safety and efficacy trial comparing a group receiving standard wound care with tumescent antibiotic injection (TAI) with a control group receiving standard wound care, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: CeFAZolin Injectable Solution, outcomesModule primaryOutcomes measure: Primary Objective - Assess the rate of occurrence and severity of adverse events and their relationship to TAI, secondaryOutcomes measure: Secondary Objective - To evaluate wound size and closure., secondaryOutcomes measure: Secondary Objective - Chronic-wound-related pain, secondaryOutcomes measure: Secondary Objective - Rating Quality of life, otherOutcomes measure: Exploratory Objectives - Assess the number of chronic wound-related complications (increased wound sizes, infections, dermatitis)., otherOutcomes measure: Exploratory Objectives - Assess the number of clinical signs of infection in participants., otherOutcomes measure: Exploratory Objectives - Determine the species of pathogenic bacteria present in wound., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06327100, orgStudyIdInfo id: 2023-0934, secondaryIdInfos id: NCI-2024-02551, type: OTHER, domain: NCI-CTRP Clinical Registry, briefTitle: Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-09-30, primaryCompletionDateStruct date: 2029-05-01, completionDateStruct date: 2031-05-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-29, sponsorCollaboratorsModule leadSponsor name: M.D. Anderson Cancer Center, class: OTHER, collaborators name: Active Biotech AB, descriptionModule briefSummary: To learn if tasquinimod either alone or in combination with ruxolitinib can help to control PMF, post-PV MF, or post-ET MF., conditionsModule conditions: Primary Myelofibrosis, conditions: Post-polycythemia Vera Myelofibrosis, conditions: Post-Essential Thrombocytosis Myelofibrosis, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NON_RANDOMIZED, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 33, type: ESTIMATED, armsInterventionsModule interventions name: Ruxolitinib, interventions name: Tasquinimod, outcomesModule primaryOutcomes measure: Safety and adverse events (AEs), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: MD Anderson Cancer Center, city: Houston, state: Texas, zip: 77030, country: United States, contacts name: Lucia Masarova, MD, role: CONTACT, phone: 832-750-4211, email: lmasarova@mdanderson.org, contacts name: Lucia Masarova, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 29.76328, lon: -95.36327, hasResults: False
protocolSection identificationModule nctId: NCT06327087, orgStudyIdInfo id: 22-00874, briefTitle: Appetite and Dietary Intake Across the Menstrual Cycle, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-06-01, primaryCompletionDateStruct date: 2025-05-31, completionDateStruct date: 2025-05-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-04, sponsorCollaboratorsModule leadSponsor name: University of British Columbia, class: OTHER, descriptionModule briefSummary: Lay language summary: Women are younger and menstruating about monthly ("pre-menopausal") often have fluctuations in the food they eat ("dietary intake") across the menstrual cycle. However, relationships between food intake and appetite, metabolism, body composition (i.e., the proportion of muscle and fat), physical activity and premenstrual symptoms have not been reported. This study will measure appetite and food intake in laboratory and usual life settings in healthy pre-menopausal women in two hormonally different parts of the menstrual cycle. Data on ovarian hormones, metabolism, body composition, physical activity and premenstrual symptoms will also be collected to assess their potential relationship with food intake., conditionsModule conditions: Appetitive Behavior, conditions: Healthy, conditions: Dietary Habits, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: PROSPECTIVE, enrollmentInfo count: 23, type: ESTIMATED, armsInterventionsModule interventions name: No intervention, outcomesModule primaryOutcomes measure: Energy intake, primaryOutcomes measure: Hunger area under the curve, primaryOutcomes measure: Satiety area under the curve, primaryOutcomes measure: Prospective food consumption area under the curve, secondaryOutcomes measure: Free-living ad libitum energy intake, secondaryOutcomes measure: Resting metabolic rate, secondaryOutcomes measure: Body composition, secondaryOutcomes measure: Estradiol, secondaryOutcomes measure: Progesterone, secondaryOutcomes measure: Physical activity patterns, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of British Columbia - Okanagan, status: RECRUITING, city: Kelowna, state: British Columbia, zip: V1V1V7, country: Canada, contacts name: Sarah Purcell, PhD, role: CONTACT, phone: 2508079827, email: sarah.purcell@ubc.ca, geoPoint lat: 49.88307, lon: -119.48568, hasResults: False
protocolSection identificationModule nctId: NCT06327074, orgStudyIdInfo id: 21-3063.cc, briefTitle: Testing the Engaged Approach to Lung Cancer Screening, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-11, primaryCompletionDateStruct date: 2025-12, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: University of Colorado, Denver, class: OTHER, collaborators name: Bristol-Myers Squibb, descriptionModule briefSummary: The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US., conditionsModule conditions: Lung Cancer, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SCREENING, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Engaged Approach to Lung Cancer Screening, outcomesModule primaryOutcomes measure: Percentage of the intervention group who would like to continue the EA-LCS framework, primaryOutcomes measure: Percentage of the intervention group who would recommend the EA-LCS framework to other programs, primaryOutcomes measure: Percentage of participants who would describe the framework as workable, secondaryOutcomes measure: Evaluate the intervention acceptability by Acceptability of Intervention Measure (AIM), secondaryOutcomes measure: Evaluate the intervention appropriateness by Intervention Appropriateness Measure (IAM), secondaryOutcomes measure: Evaluate the intervention feasibility by Feasibility of Intervention Measure (FIM), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Colorado Hospital, status: RECRUITING, city: Denver, state: Colorado, zip: 80045, country: United States, contacts name: Jamie Studts, role: CONTACT, email: Jamie.Studts@CUANSCHUTZ.EDU, contacts name: Jamie Studts, PhD, role: PRINCIPAL_INVESTIGATOR, contacts name: Erin Hirsch, role: SUB_INVESTIGATOR, geoPoint lat: 39.73915, lon: -104.9847, hasResults: False
protocolSection identificationModule nctId: NCT06327061, orgStudyIdInfo id: R01DA058659, type: NIH, link: https://reporter.nih.gov/quickSearch/R01DA058659, secondaryIdInfos id: IRB00026607, type: OTHER, domain: JHSPH IRB, briefTitle: Social Network Overdose Prevention and Education Intervention, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2027-06-01, completionDateStruct date: 2027-12-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: Johns Hopkins Bloomberg School of Public Health, class: OTHER, collaborators name: National Institute on Drug Abuse (NIDA), descriptionModule briefSummary: The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs)., conditionsModule conditions: Drug Overdose, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: a standard two-group clinical trial, one group is the experimental, the other the control, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, maskingDescription: Both groups receive overdose prevention training, whoMasked: PARTICIPANT, enrollmentInfo count: 600, type: ESTIMATED, armsInterventionsModule interventions name: Network overdose prevention, interventions name: Standard of care health education, outcomesModule primaryOutcomes measure: Number of drug overdoses, primaryOutcomes measure: Participant drug use, secondaryOutcomes measure: Number of Network member contacts, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Johns Hopkins Bloomberg School of Public Health, city: Baltimore, state: Maryland, zip: 21205, country: United States, geoPoint lat: 39.29038, lon: -76.61219, hasResults: False
protocolSection identificationModule nctId: NCT06327048, orgStudyIdInfo id: School of Nursing, briefTitle: Application of Cognitive Training Based on Remind Strategy in Glioma Patients With Cognitive Impairment, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-06, primaryCompletionDateStruct date: 2024-11-30, completionDateStruct date: 2024-12-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: YuanYuan Ma, class: OTHER, descriptionModule briefSummary: The purpose of this study is to form an interdisciplinary team to dynamically evaluate patient cognitive outcomes and develop an individualized cognitive training program for Chinese brain tumor patients, conditionsModule conditions: Glioma, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Non-randomized intervention study, primaryPurpose: OTHER, maskingInfo masking: SINGLE, maskingDescription: Blind the evaluator, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 72, type: ESTIMATED, armsInterventionsModule interventions name: Individual cognitive rehabilitation training based on Remind strategy was given, outcomesModule primaryOutcomes measure: Montreal Cognitive Assessment(MoCA), secondaryOutcomes measure: The European Organization for Research and Treatment of Cancer core Quality of Life Questionnaire (EORTC QLQ-C30), secondaryOutcomes measure: The EORTC QLQ-Brain Neoplasms 20(EORTC QLQ-BN20), secondaryOutcomes measure: Self-Rating Anxiety Scale(SAS), secondaryOutcomes measure: Self-Rating Depression Scale(SDS), secondaryOutcomes measure: Modified Barthel Index(MBI), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Yuanyuanma, status: RECRUITING, city: Lanzhou, state: Gansu, country: China, contacts name: yuanyuan ma, Bachelor, role: CONTACT, phone: 15294126094, email: 1657107645@qq.com, geoPoint lat: 36.05701, lon: 103.83987, hasResults: False
protocolSection identificationModule nctId: NCT06327035, orgStudyIdInfo id: 2023-A02660-45, briefTitle: Evolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center, acronym: PROWALK, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-26, primaryCompletionDateStruct date: 2025-04-01, completionDateStruct date: 2025-04-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Clinique Les Trois Soleils, class: OTHER, collaborators name: Le Normandy, descriptionModule briefSummary: The goal of this observational study is to describe the evolution of gait recovery during the subacute phase of stroke up to six months after stroke, in patients hospitalized in medical and neurological rehabilitation units., conditionsModule conditions: Stroke, conditions: Gait, Hemiplegic, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 400, type: ESTIMATED, armsInterventionsModule interventions name: Gait rehabilitation, outcomesModule primaryOutcomes measure: Functional Ambulation Classification, secondaryOutcomes measure: Postural Assesment Scale for Stroke Patient, secondaryOutcomes measure: Timed Up and Go, secondaryOutcomes measure: 10-Meter Walk Test, secondaryOutcomes measure: 6Minute-Walk Test, secondaryOutcomes measure: Motricity Index, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06327022, orgStudyIdInfo id: P0038444, briefTitle: Social Media-based Electronic Bibliotherapy for Dementia Caregivers, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-07-01, primaryCompletionDateStruct date: 2023-12-31, completionDateStruct date: 2023-12-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: The Hong Kong Polytechnic University, class: OTHER, descriptionModule briefSummary: This study aims to assess the efficacy of social media-based electronic bibliotherapy in improving the well-being of informal caregivers of people with dementia compared to a control group., conditionsModule conditions: Mental Health, conditions: Quality of Life, conditions: Dementia Caregivers, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Social media-based electronic bibliotherapy, interventions name: Usual care, outcomesModule primaryOutcomes measure: Changes in mental health, secondaryOutcomes measure: Changes in health related quality of life, secondaryOutcomes measure: Changes in caregiving appraisal, secondaryOutcomes measure: Changes in psychological wellbeing, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The Hong Kong Polytechnic University, city: Kowloon, country: Hong Kong, geoPoint lat: 22.31667, lon: 114.18333, hasResults: False
protocolSection identificationModule nctId: NCT06327009, orgStudyIdInfo id: fasting ramadan in GN patients, briefTitle: Effect of Ramadan Fasting on Kidney Function and Proteinuria in Patients With Glomerulonephritis, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-22, primaryCompletionDateStruct date: 2024-04-22, completionDateStruct date: 2024-05-22, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Alexandria University, class: OTHER, descriptionModule briefSummary: This research aims to assess effects of ramadan fasting on kidney function and proteinuria in patients with glomerulonephritis., conditionsModule conditions: Fasting Ramadan, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: fasting month of ramadan, outcomesModule primaryOutcomes measure: Change in kidney function, primaryOutcomes measure: Change in proteinuria, eligibilityModule sex: ALL, minimumAge: 18 Months, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Medicine, Aexandria University, city: Alexandria, zip: 21526, country: Egypt, contacts name: Mohamed Mamdouh Elsayed, MD, role: CONTACT, email: dr_mohamedmamdouh87@yahoo.com, geoPoint lat: 31.21564, lon: 29.95527, hasResults: False
protocolSection identificationModule nctId: NCT06326996, orgStudyIdInfo id: 23-001185, briefTitle: Thiamine Intervention and Coronary Artery Bypass Grafting, acronym: B1&CABG, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2026-01, completionDateStruct date: 2026-05, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-01, sponsorCollaboratorsModule leadSponsor name: University of California, Los Angeles, class: OTHER, descriptionModule briefSummary: The purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects., conditionsModule conditions: Coronary Heart Disease, conditions: Coronary Artery Bypass Grafting, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Post-CABG patients with and without thiamine treatment., primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: Participants will be assigned a random number, double-blind randomized, \& longitudinal study design., whoMasked: PARTICIPANT, enrollmentInfo count: 52, type: ESTIMATED, armsInterventionsModule interventions name: Thiamine, interventions name: Placebo, outcomesModule primaryOutcomes measure: Effects of thiamine treatment intervention on blood lactate levels., primaryOutcomes measure: Effects of thiamine treatment intervention on blood thiamine levels., primaryOutcomes measure: Effects of thiamine treatment intervention on blood inflammatory levels., primaryOutcomes measure: Evaluate cognitive function in CABG patients with thiamine treatment., primaryOutcomes measure: Evaluate long term effects of thiamine treatment intervention on cognitive function in CABG patients with thiamine treatment., primaryOutcomes measure: Examine cognition in CABG patients with thiamine treatment., primaryOutcomes measure: Examine long term effects of thiamine treatment intervention on cognition in CABG patients with thiamine treatment., primaryOutcomes measure: Cognition assessment in CABG patients after thiamine treatment., primaryOutcomes measure: Assessment of long term effects of thiamine treatment intervention on cognition in CABG patients after thiamine treatment., primaryOutcomes measure: Long term effect of thiamine treatment intervention on quality of life., primaryOutcomes measure: Long term effect of thiamine treatment intervention on daily activities using PASE., primaryOutcomes measure: Long term effect of thiamine treatment intervention on daily activities using PPA., eligibilityModule sex: ALL, minimumAge: 60 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: UCLA, city: Los Angeles, state: California, zip: 90095, country: United States, geoPoint lat: 34.05223, lon: -118.24368, hasResults: False